Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Director · 10% owner | April 28, 2021 | April 28, 2021 |
| Surgery Partners, Inc.SGRY · Entity 4534 | Director · 10% owner | December 19, 2023 | December 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date April 28, 2021 · Filed April 28, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee footnotes | 81,029,675 |
Reported balance
Holding disclosure · report date 2021-04-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 81,029,675 F1: Represents shares of common stock held by Bain Capital Fund XI, L.P. ("Fund XI"), BCIP Associates IV (US), L.P. ("BCIP IV"), BCIP Associates IV-B (US), L.P. ("BCIP IV-B"), BCIP T Associates IV (US), L.P. ("BCIP T IV") and BCIP T Associates IV-B (US), L.P. ("BCIP T IV-B" and, together with Fund IX, BCIP IV, BCIP IV-B and BCP T IV, collectively, the "Bain Capital Entities"). F2: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of the Fund IX and governs the investment strategy and decision-making process with respect to investments held by BCIP IV, BCIP IV-B, BCIP T IV and BCIP T IV-B. Mr. O'Reilly is a Managing Director of BCI. As a result of the relationships described in this footnote, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock held by Bain Capital Fund XI, L.P. ("Fund XI"), BCIP Associates IV (US), L.P. ("BCIP IV"), BCIP Associates IV-B (US), L.P. ("BCIP IV-B"), BCIP T Associates IV (US), L.P. ("BCIP T IV") and BCIP T Associates IV-B (US), L.P. ("BCIP T IV-B" and, together with Fund IX, BCIP IV, BCIP IV-B and BCP T IV, collectively, the "Bain Capital Entities").
F2: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of the Fund IX and governs the investment strategy and decision-making process with respect to investments held by BCIP IV, BCIP IV-B, BCIP T IV and BCIP T IV-B. Mr. O'Reilly is a Managing Director of BCI. As a result of the relationships described in this footnote, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Surgery Partners, Inc.
Report date December 19, 2023 · Filed December 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 49,946,972 |
Last balance in matching sequence
After 2023-12-19 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-12-19 · Sale · Disposed 7,826,870 · Balance 50,421,379 F1: Represents shares of Common Stock held directly by BCPE Seminole Holdings LP ("BCPE Seminole"), BCPE Seminole Holdings II Intermediate LP ("BCPE Seminole II"), BCPE Seminole Holdings III, L.P. ("BCPE Seminole III") and BCPE Seminole Holdings IV, L.P. ("BCPE Seminole IV" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the "Bain Capital Entities"). F2: Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. O'Reilly is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Row 2 · 2023-12-19 · Other · Disposed 474,407 · Balance 49,946,972 F3: On December 19, 2023, BCPE Seminole distributed 474,407 shares of Common Stock to one or more members or partners, including 3,605 shares of Common Stock to Mr. O'Reilly in connection with certain charitable gifts made by such members or partners or their direct or indirect owners, including Mr. O'Reilly. F1: Represents shares of Common Stock held directly by BCPE Seminole Holdings LP ("BCPE Seminole"), BCPE Seminole Holdings II Intermediate LP ("BCPE Seminole II"), BCPE Seminole Holdings III, L.P. ("BCPE Seminole III") and BCPE Seminole Holdings IV, L.P. ("BCPE Seminole IV" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the "Bain Capital Entities"). F2: Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. O'Reilly is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-12-19 transaction · row 3
1 source rowRow 3 · 2023-12-19 · Gift · Disposed 3,605 · Balance 0 F4: Mr. O'Reilly made a charitable gift of all 3,605 shares of Common Stock that he received in connection with the distribution described in footnote 3 above. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock held directly by BCPE Seminole Holdings LP ("BCPE Seminole"), BCPE Seminole Holdings II Intermediate LP ("BCPE Seminole II"), BCPE Seminole Holdings III, L.P. ("BCPE Seminole III") and BCPE Seminole Holdings IV, L.P. ("BCPE Seminole IV" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the "Bain Capital Entities").
F2: Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. O'Reilly is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F3: On December 19, 2023, BCPE Seminole distributed 474,407 shares of Common Stock to one or more members or partners, including 3,605 shares of Common Stock to Mr. O'Reilly in connection with certain charitable gifts made by such members or partners or their direct or indirect owners, including Mr. O'Reilly.
F4: Mr. O'Reilly made a charitable gift of all 3,605 shares of Common Stock that he received in connection with the distribution described in footnote 3 above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2023 Filed Dec 22, 2023 01:21 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GiftCommon Stock | 3,605 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-020681 · doc4.xml · nonDerivative · entry 3 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F4 · kind: Mr. O'Reilly made a charitable gift of all 3,605 shares of Common Stock that he received in connection with the distribution described in footnote 3 above. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 01:21 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | OtherCommon Stock | 474,407 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-020681 · doc4.xml · nonDerivative · entry 2 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 49,946,972 F3 · kind: On December 19, 2023, BCPE Seminole distributed 474,407 shares of Common Stock to one or more members or partners, including 3,605 shares of Common Stock to Mr. O'Reilly in connection with certain charitable gifts made by such members or partners or their direct or indirect owners, including Mr. O'Reilly. F1 · ownership.nature: Represents shares of Common Stock held directly by BCPE Seminole Holdings LP ("BCPE Seminole"), BCPE Seminole Holdings II Intermediate LP ("BCPE Seminole II"), BCPE Seminole Holdings III, L.P. ("BCPE Seminole III") and BCPE Seminole Holdings IV, L.P. ("BCPE Seminole IV" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. O'Reilly is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 01:21 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 7,826,870 | $33.44 | $261,730,532.80 |
DisclosureSEC source: 0000899243-23-020681 · doc4.xml · nonDerivative · entry 1 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 50,421,379 F1 · ownership.nature: Represents shares of Common Stock held directly by BCPE Seminole Holdings LP ("BCPE Seminole"), BCPE Seminole Holdings II Intermediate LP ("BCPE Seminole II"), BCPE Seminole Holdings III, L.P. ("BCPE Seminole III") and BCPE Seminole Holdings IV, L.P. ("BCPE Seminole IV" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. O'Reilly is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. O'Reilly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 21:15 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 9,183,673 | $24.50 | $224,999,988.50 |
DisclosureSEC source: 0000899243-22-036915 · doc4.xml · nonDerivative · entry 1 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 58,248,249 F1 · kind: On November 21, 2022, Bain Capital Fund XI, L.P. ("Fund XI") entered into a stock purchase agreement with the Issuer pursuant to which the Issuer agreed to issue and sell 9,183,673 shares of Common Stock to Fund XI at a price of $24.50 per share, for an aggregate purchase price of $224,999,988.50 (the "Private Placement"). The closing of the Private Placement was contingent on the closing of the Issuer's concurrent underwritten offering, which closed on November 23, 2022. The Private Placement is expected to close within 30 days of the date hereof, subject to the satisfaction of customary closing conditions. F2 · ownership.nature: Represents shares of Common Stock held by BCPE Seminole Holdings LP ("BCPE Seminole") and Fund XI. Bain Capital Investors, LLC ("BCI") is the (i) sole member of BCPE Seminole GP LLC, which is the general partner of BCPE Seminole, and (ii) general partner of Bain Capital Partners XI, L.P., which is the general partner of Fund XI. Devin O'Reilly is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the securities held by BCPE Seminole and Fund XI. Mr. O'Reilly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2021 Filed May 19, 2021 23:19 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionSeries A Convertible Perpetual Participating Preferred Stock · Derivative | 310,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-020019 · doc4.xml · derivative · entry 2 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 22,608,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series A Convertible Perpetual Participating Preferred Stock (the "Series A Preferred Stock") was convertible into the number of shares of common stock of the Issuer equal to the quotient obtained by dividing (a) the accrued value of such share of Series A Preferred Stock (initially, $1,000) plus any accrued but uncompounded dividends on such share by (b) the $19.00 conversion price, subject to certain anti-dilution adjustments in accordance with the terms as set forth in the Series A Preferred Stock Certificate of Designation. Dividends accrued daily and compounded quarterly on March 31, June 30, September 30 and December 31 of each year and were added to the accrued value of a share. The Series A Preferred Stock did not have an expiration date. F3 · derivative.exercise_price: On May 17, 2021, the 310,000 shares of Series A Preferred Stock held by BCPE Holdings were converted into 22,608,925 shares of common stock of the Issuer following the Issuer's exercise of its optional conversion right pursuant to the terms of the Series A Preferred Stock Certificate of Designation. F2 · price: Each share of Series A Convertible Perpetual Participating Preferred Stock (the "Series A Preferred Stock") was convertible into the number of shares of common stock of the Issuer equal to the quotient obtained by dividing (a) the accrued value of such share of Series A Preferred Stock (initially, $1,000) plus any accrued but uncompounded dividends on such share by (b) the $19.00 conversion price, subject to certain anti-dilution adjustments in accordance with the terms as set forth in the Series A Preferred Stock Certificate of Designation. Dividends accrued daily and compounded quarterly on March 31, June 30, September 30 and December 31 of each year and were added to the accrued value of a share. The Series A Preferred Stock did not have an expiration date. F3 · price: On May 17, 2021, the 310,000 shares of Series A Preferred Stock held by BCPE Holdings were converted into 22,608,925 shares of common stock of the Issuer following the Issuer's exercise of its optional conversion right pursuant to the terms of the Series A Preferred Stock Certificate of Designation. F2 · derivative.exercise_date: Each share of Series A Convertible Perpetual Participating Preferred Stock (the "Series A Preferred Stock") was convertible into the number of shares of common stock of the Issuer equal to the quotient obtained by dividing (a) the accrued value of such share of Series A Preferred Stock (initially, $1,000) plus any accrued but uncompounded dividends on such share by (b) the $19.00 conversion price, subject to certain anti-dilution adjustments in accordance with the terms as set forth in the Series A Preferred Stock Certificate of Designation. Dividends accrued daily and compounded quarterly on March 31, June 30, September 30 and December 31 of each year and were added to the accrued value of a share. The Series A Preferred Stock did not have an expiration date. F2 · derivative.expiration_date: Each share of Series A Convertible Perpetual Participating Preferred Stock (the "Series A Preferred Stock") was convertible into the number of shares of common stock of the Issuer equal to the quotient obtained by dividing (a) the accrued value of such share of Series A Preferred Stock (initially, $1,000) plus any accrued but uncompounded dividends on such share by (b) the $19.00 conversion price, subject to certain anti-dilution adjustments in accordance with the terms as set forth in the Series A Preferred Stock Certificate of Designation. Dividends accrued daily and compounded quarterly on March 31, June 30, September 30 and December 31 of each year and were added to the accrued value of a share. The Series A Preferred Stock did not have an expiration date. F1 · ownership.nature: Represents securities held directly by BCPE Seminole Holdings LP ("BCPE Holdings"). Bain Capital Investors, LLC ("BCI") is the sole member of BCPE Seminole GP LLC, which is the general partner of BCPE Holdings. T. Devin O'Reilly is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the securities held by BCPE Holdings. Mr. O'Reilly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2021 Filed May 19, 2021 23:19 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionCommon Stock | 22,608,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-020019 · doc4.xml · nonDerivative · entry 1 O'Reilly T. Devin · CIK 0001712887 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 49,064,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series A Convertible Perpetual Participating Preferred Stock (the "Series A Preferred Stock") was convertible into the number of shares of common stock of the Issuer equal to the quotient obtained by dividing (a) the accrued value of such share of Series A Preferred Stock (initially, $1,000) plus any accrued but uncompounded dividends on such share by (b) the $19.00 conversion price, subject to certain anti-dilution adjustments in accordance with the terms as set forth in the Series A Preferred Stock Certificate of Designation. Dividends accrued daily and compounded quarterly on March 31, June 30, September 30 and December 31 of each year and were added to the accrued value of a share. The Series A Preferred Stock did not have an expiration date. F3 · price: On May 17, 2021, the 310,000 shares of Series A Preferred Stock held by BCPE Holdings were converted into 22,608,925 shares of common stock of the Issuer following the Issuer's exercise of its optional conversion right pursuant to the terms of the Series A Preferred Stock Certificate of Designation. F1 · ownership.nature: Represents securities held directly by BCPE Seminole Holdings LP ("BCPE Holdings"). Bain Capital Investors, LLC ("BCI") is the sole member of BCPE Seminole GP LLC, which is the general partner of BCPE Holdings. T. Devin O'Reilly is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. O'Reilly may be deemed to share voting and dispositive power with respect to the securities held by BCPE Holdings. Mr. O'Reilly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.